of the Pd catalyst in homogeneous-phase reactions, the
use of polymer-bound triphenylphosphine was investi-
gated, but remained without effect. Using aryl bromides
on solid phase in a heavy-walled Smith vial equipped
with a polypropylene frit, the Sonogashira couplings
could be rapidly performed, and the resin-bound sub-
on a rotatory evaporator, followed by removal of remaining
solvent under reduced pressure overnight.
Meth od B. Loa d in g of 3-Br om oben zoic Acid on to th e
Rin k Am id e Resin (B1). Procedure A1 was followed with the
exception of using a resin with a loading of 0.69 mmol/g and
using 3-bromobenzoic acid (0.78 mmol, 156.8 mg) instead of the
iodo-derivative, yielding 3-bromophenyl-derivatized Rink amide
resin. The substitution level was determined to be 0.39 mmol/g
by cleavage of 3-bromophenylamide following procedure A3.
Son oga sh ir a Cou p lin g on Br om op h en yl Resin (B2) a n d
Clea va ge a n d P u r ifica tion of th e Ar yla cetylen es (B3). The
3
strates could easily be separated from PPh .
In conclusion, we have developed a general procedure
for rapid Sonogashira coupling of aryl iodides and
bromides on solid phase. Furthermore, a modified heavy-
walled glass vial equipped with a polypropylene frit is
introduced, allowing both microwave heating and simpli-
fied resin handling. The described procedure should prove
valuable for the fast automatized generation of chemical
libraries.
3
-bromophenyl resin obtained in procedure B1 (500 mg, 0.39
mmol/g), Pd(PPh Cl (13.7 mg, 0.020 mmol), CuI (7.4 mg, 0.039
3
)
2
2
mmol), triphenylphosphine (20.5 mg, 0.078 mmol), the acetylene
derivative 1-6 (0.43 mmol), diethylamine (1.5 mL, 13.60 mmol),
and DMF (0.5 mL) were stirred in a modified heavy-walled
Smith Process Vial at 120 °C for 25 min in the microwave cavity.
Subsequent workup followed the procedure described for meth-
ods A2 and A3.
3
-Iod oben za m id e.13 Method A: 59.0 mg, 0.239 mmol, 62%,
white solid, corresponding to a loading rate of 0.48 mmol/g. Mp:
Exp er im en ta l Section
1
Gen er a l Com m en ts. For a general description of methods
and microwave irradiation procedures, see ref 2.
Ma ter ia ls. The starting materials were purchased from
commercial suppliers and were used without purification with
the exception of (3-ethynylphenyl)carbamic acid tert-butyl ester
183-184 °C. H NMR (400 MHz, CD OD): δ 8.22 (dd, J ) 1.1,
3
1.1 Hz, 1H, H-2), 7.89 (ddd, J ) 1.1, 1.6, 7.9 Hz, 1H, H-6), 7.86
(
ddd, J ) 1.1, 1.6, 7.9 Hz, H-4), 7.23 (dd, J ) 7.9, 7.9 Hz, H-5).
1
3
C NMR (100 MHz, CD
3
OD): δ 169.2, 140.5, 136.5, 135.7, 130.0,
+
1
(
26.6, 93.4. EI-MS m/z (relative intensity): 247 (M , 100), 231
-
1
84), 203 (40), 127 (16), 76 (82). IR ν (cm ): 3404, 3202, 1665.
-Br om oben za m id e.14 Method B: 39.2 mg, 0.195 mmol,
7%, white solid, giving a loading rate of 0.39 mmol/g. Mp: 153-
(
9
3-ethynyl-Boc-aniline) and (3-ethynylphenyl)carbamic acid
H-fluoren-9-ylmethyl ester (3-ethynyl-Fmoc-aniline), which
were prepared from 3-ethynylaniline using standard protection
3
5
1
1
1
154 °C. H NMR (400 MHz, CDCl
3
): δ 7.91 (dd, J ) 1.8, 1.8 Hz,
H, H-2), 7.68 (ddd, J ) 1.1, 1.8, 7.8 Hz, 1H, H-6), 7.56 (J ) 1.1,
.8, 7.8 Hz, H-4), 7.23 (dd, J ) 7.8, 7.8 Hz, H-5). 13C NMR (100
): δ 168.9, 135.3, 134.9, 130.7, 130.1, 126.1, 122.6.
procedures.
1
1
Meth od A. Loa d in g of 3-Iod oben zoic Acid on to th e Rin k
Am id e Resin (A1). To 500 mg of Rink amide linker attached
MHz, CDCl
EI-MS m/z (relative intensity) 201 (M , 73), 200 (M , 59), 185
3
to polystyrene resin (loading 0.78 mmol/g) were added DMF (3
+
+
mL), 3-iodobenzoic acid (0.78 mmol, 193.5 mg), PyBOP12 (0.78
-
1
(
96), 183 (100), 76 (18). IR ν (cm ): 3560, 3180, 1640.
-Eth yn ylben za m id e. (1A) Method A: 91.5 mg, white solid
containing 32.8 mg, 0.226 mmol, 94% product. (1B) Method B:
7.9 mg, yellowish solid containing 27.9 mg, 0.191 mmol, 97%
product. H NMR (400 MHz, CD
.3 Hz, 1H, H-2), 7.86 (ddd, J ) 1.3, 1.8, 7.9 Hz, 1H, H-6), 7.62
ddd, J ) 1.3, 1.8, 7.7 Hz, 1H, H-4), 7.45 (ddd, J ) 0.6, 7.7, 7.9
Hz, 1H, H-5). C NMR (100 MHz, CD
34.1, 130.8, 128.5, 127.6, 122.9, 82.2, 78.4. EI-MS m/z (relative
mmol, 405.8 mg), and diisopropylethylamine (1.34 mmol, 0.4
mL). The mixture was stirred in a modified heavy-walled Smith
Process Vial under microwave irradiation at 110 °C for 20 min,
then washed with DMF, ethanol, and dichloromethane to yield
3
5
1
3
OD): δ 7.96 (ddd, J ) 0.6, 1.3,
3
-iodophenyl-derivatized Rink amide resin. The substitution
level of the iodophenyl-derivatized resin was determined to be
.48 mmol/g by cleavage and quantification of 3-iodophenylamide
1
(
0
1
3
3
OD): δ 170.0, 134.8,
following procedure A3.
Son oga sh ir a Cou p lin g on Iod op h en yl Resin (A2). The
1
+
intensity): 145 (M , 63), 129 (79), 101 (100), 75 (71), 51 (39). IR
ν (cm ): 3682, 3622, 2398, 1518. Anal. (C
3
-iodophenyl-resin obtained in procedure A1 (500 mg, 0.48 mmol/
g), Pd(PPh Cl (8.2 mg, 0.012 mmol), CuI (4.5 mg, 0.024 mmol),
the acetylene derivative 1-6 (0.43 mmol), diethylamine (1.5 mL,
3.60 mmol), and DMF (0.5 mL) were stirred in a modified
-
1
9 7
H NO) C, H, N.
3
)
2
2
3
-P h en yleth yn ylben za m id e. (2A) Method A: 47.0 mg,
white solid (0.212 mmol, 89%). (2B) Method B: 39.7 mg 27.9
1
1
mg, white solid (0.179 mmol, 92%). Mp: 164-165 °C. H NMR
heavy-walled Smith Process Vial at 120 °C for 15 min in the
microwave cavity. The mixture was then washed with DMF,
ethanol, and dichloromethane.
(
(
3
400 MHz, CDCl ): δ 7.94 (dd, J ) 1.5, 1.7 Hz, 1H, H-2), 7.75
ddd, J ) 1.3, 1.7, 7.9 Hz, 1H, H-6), 7.63 (ddd, J ) 1.3, 1.5, 7.9
Hz, 1H, H-4), 7.46-7.51 (m, 2H, AA′ part of AA′BB′C), 7.40 (dd,
Clea va ge a n d P u r ifica t ion of t h e Ar yla cet ylen e (A3).
Four milliliters of 95% trifluoroacetic acid was added to the resin,
and the mixture was stirred in a modified heavy-walled Smith
Process Vial at 70 °C for 20 min in the microwave cavity. The
mixture was then filtered, and the resulting solution was
concentrated on a rotatory evaporator. The residue was extracted
with aqueous sodium hydroxide solution (pH ) 12), reextracting
the aqueous phase with dichloromethane twice. After filtration
J ) 7.9, 7.9 Hz, 1H, H-5), 7.29-7.35 (m, 3H, BB′C part of
13
3
AA′BB′C). C NMR (100 MHz, CDCl ): δ 169.9, 134.7, 133.6,
1
31.5, 130.6, 128.6, 128.5, 128.4, 127.2, 123.8, 122.7, 90.2, 88.2.
+
EI-MS m/z (relative intensity): 221 (M , 100), 205 (61), 176 (79),
1
(C H
15
-1
51 (32), 88 (18). IR ν (cm ): 3522, 3413, 2392, 1674. Anal.
11NO) C, H, N.
E)-3-(3′-Oxo-3-p h en ylp r op -1-en yl)b en za m id e.
1
3
(
(3A)
Method A: 55.9 mg, white solid (0.222 mmol, 92%). (3B) Method
4
of the combined organic layers through MgSO , they were
B: 48.4 mg, white solid (0.193 mmol, 98%). Mp: 153-154 °C.
concentrated under reduced pressure. The further purification
of 3-ethynylbenzamide and 3-(3-aminophenylethynyl)benzamide
was omitted because of their tendency to adsorb on silica, and
1
H NMR (400 MHz, CDCl ): δ 8.15 (dd, J ) 1.8, 1.8 Hz, 1H,
3
H-2), 8.06 (m, 2H, AA′ part of AA′BB′C), 7.83 (d, J ) 15.8 Hz,
H, CdC-H), 7.81 (ddd, J ) 1.1, 1.8, 7.7 Hz, 1H, H-6), 7.79
ddd, J ) 1.1, 1.8, 7.7 Hz, 1H, H-4), 7.62 (d, J ) 15.8 Hz, 1H,
CdC-H), 7.61 (ddd, J ) 1.1, 1.1, 7.7 Hz, 1H, H-5), 7.52 (m, 3H,
BB′ and C part of AA′BB′C). 13C NMR (100 MHz, CDCl
): δ
91.0, 170.3, 143.1, 137.8, 135.2, 134.4, 133.1, 131.9, 129.5, 129.1,
1
(
1
these compounds were therefore quantified by H NMR using
hydroquinone diacetate as an internal standard. In the case of
all other arylacetylene derivatives, the obtained residue was
purified by column chromatography (silica gel 60, particle size
3
1
0
1
.040-0.063 mm, hexane/ethyl acetate stepwise gradient from
2:1 to 1:1). The combined product fractions were concentrated
(13) Reich, S. H.; J ohnson, T.; Wallace, M. B.; Kephart, S. E.;
Fuhrman, S. A.; Worland, S. T.; Matthews, D. A.; Hendrickson, T. F.;
Chan, F.; Meador, M.; Ferre, R. A.; Brown, E. L.; DeLisle, D. M.; Patick,
A. K.; Binford, S. L.; Ford C. E. J . Med. Chem. 2000, 43, 1670.
(14) Pearson, D. E.; Stanper, W. E.; Suthers, B. R. J . Org. Chem.
1963, 3147.
(
11) Protecting groups in Organic Chemistry; Greene, T. W., Wuts,
P. G. M., Eds.; J ohn Wiley & Sons Inc.: New York, 1999.
12) PyBOP ) benzotriazol-1-yloxytrispyrrolidinophosphoniumhexa-
fluorophosphate.
(
J . Org. Chem, Vol. 68, No. 16, 2003 6433